RP
AVNS icon

RR Partners’s Avanos Medical AVNS Stock Holding History

RR Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-629,401
Closed -$17.9M – 20
2015
Q3 		$17.9M Sell
629,401
-1,271,199
-67% -$44.3M 0.77% 17
2015
Q2 		$77M Hold
1,900,600
– – 2.85% 13
2015
Q1 		$93.5M Hold
1,900,600
– – 2.86% 15
2014
Q4 		$86.4M Buy
+1,900,600
New +$74.7M 2.71% 14

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

RR Partners's AVNS Position: Q4 2015 in Review

RR Partners sold out of Avanos Medical (AVNS) in Q4 2015, closing a stake of 629,401 shares — an estimated $17.9M sold.

RR Partners first reported a position in AVNS in Q4 2014 and held it in 4 quarters. The position peaked at $93.5M in Q1 2015. 349 funds tracked by Wall St. Rank hold AVNS as of Q4 2015.

  • RR Partners reported no remaining Avanos Medical position as of Q4 2015 after selling out during the quarter.
  • RR Partners sold 629,401 Avanos Medical shares in Q4 2015, an estimated $17.9M.
  • RR Partners first reported a position in Avanos Medical in Q4 2014 and held it in 4 quarters.
  • RR Partners's Avanos Medical position peaked at $93.5M in Q1 2015.
  • 349 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2015.

Based on RR Partners's 13F filing for Q4 2015, filed 16 Feb 2016.